Progress Fueled by Purpose

Bridge To A Cure is driving systemic change in childhood cancer research by demanding shared infrastructure, collaboration, and accountability. Their partnership supports CBTN’s role as a unifying force in pediatric brain tumor research, building the data and operational backbone needed to accelerate discovery and translate patient contributions into cures.

Born from Carson’s legacy, the foundation fuels innovation in medulloblastoma and pediatric brain tumor research. Its investment in targeted data generation and precision medicine reflects a shared commitment to turning patient stories into actionable discoveries.

CBTF was among the first philanthropic partners to invest in CBTN, helping to lay the groundwork for its open-science model. Its continued support reflects a long-term commitment to advancing research infrastructure, improving access to shared data, and ensuring that families and patients remain at the heart of progress.

Dragon Master Initiative has been a catalyst for open science from CBTN’s earliest days, helping build the data-sharing ecosystem that now powers discovery globally. Its leadership in advocating for shared infrastructure has shaped CBTN’s trajectory, ensuring data is collected, harmonized, and made accessible to the entire research community.

Head for the Cure mobilizes communities nationwide to support research and awareness. Its sustained support strengthens CBTN’s site infrastructure and expands the network’s reach, ensuring more patients and families can contribute to and benefit from open science.

Infinite Love channels the power of community into research infrastructure. Its annual Tutu Trot, which draws over 1,000 runners and raises more than $100,000 each year, is a cornerstone of its commitment to CBTN. This sustained investment directly supports the backbone systems that enable data generation and sharing at scale, ensuring that patient contributions become part of a growing engine for discovery.

Among CBTN’s earliest funders, Kortney Rose Foundation helped build core infrastructure to support DIPG research and data sharing. Its legacy funding ensures that work continues, keeping rare and aggressive tumors represented in global datasets.

Lauren’s First and Goal channels broad community energy into research. Its project support for low-grade glioma strengthens CBTN’s infrastructure to advance disease-specific precision science.

The Lilabean Foundation has been one of CBTN’s most deeply engaged partners, providing multiyear, catalytic funding for core infrastructure. Its CBTN investments enable more precise and scalable preclinical research. The Lilabean also has supported Project Accelerate, equipping the research community to move faster. Its commitment reflects a strategic, long-term vision to transform how research is conducted and shared.

Making Headway blends family support with strategic investment in research infrastructure. Its partnership helped integrate NYU site data and biobanking into CBTN, ensuring families and patients are part of the global research engine.

Driven by McKenna’s legacy, the foundation channels community energy into high-impact research. Its sustained support strengthens CBTN’s collaborative infrastructure and ensures that data generated from patient contributions drives real progress.

The Musella Foundation focuses on high-risk cancers such as DMG and glioblastoma while championing data sharing that serves patients across their lifespan. Its partnership reinforces CBTN’s ability to integrate pediatric data into broader research ecosystems and drive innovation for all patients.

Ollie’s Orchestra channels love, art, and advocacy into research. As a Champion, it amplifies CBTN’s mission to transform individual stories into collective power and lasting change.

As the largest patient advocacy funder dedicated to childhood brain tumors, PBTF has been a CBTN partner for more than a decade. Guided by its Care. Cure. Thrive. mission, PBTF’s investment has sustained the infrastructure that underpins CBTN’s global impact. Its commitment strengthens open science, ensuring that every child’s story contributes to meaningful discovery and faster progress.

Pied Piper’s commitment reflects their focus on ependymoma and rare tumors, as well as their support for preclinical and data infrastructure to make future trials more precise and impactful. Its partnership with CBTN strengthens the research pathways that bring better treatments to children faster.

Created in Reid’s honor, the foundation channels advocacy into lasting infrastructure. Its support expands CBTN’s network reach, including efforts to bring Iowa into the consortium, strengthening national collaboration.

The Rally Foundation empowers communities to fund transformative pediatric cancer research through collaboration-first philanthropy. Its partnership with CBTN focuses on advancing collaborative initiatives that strengthen shared infrastructure, accelerate data-driven discovery, and expand access to research resources across institutions.

Dedicated to children with craniopharyngioma, RAWF ensures rare tumor types are represented in global datasets. Its support expands CBTN’s data ecosystem and reflects a commitment to inclusive, infrastructure-driven progress.

RCD Foundation is building shared data infrastructure across Australia, extending CBTN’s impact globally. Its investment strengthens international collaboration and long-term architecture for open data.

Founded by Ellyn Miller in honor of her daughter Gabriella, Smashing Walnuts’ advocacy was instrumental in establishing the Gabriella Miller Kids First Pediatric Research program, home of the CBTN PBTA dataset. Its ongoing partnership underscores the power of advocacy to catalyze infrastructure change and accelerate discovery.

The Swifty Foundation has fundamentally changed pediatric brain tumor research through its leadership of Gift from a Child, the national postmortem tissue donation initiative. Its partnership with CBTN has created the backbone of the largest postmortem pediatric brain tumor collection in the world, embedding GFAC within the network’s infrastructure to ensure these contributions are not only honored but also fuel high-value, globally accessible research for years to come.

The mission of The Ross K. MacNeill Foundation is to end pediatric brain cancer by funding research that will rapidly develop innovative, nontoxic therapies to put to end the devastating diagnosis of pediatric brain cancer.

Tommy Strong’s support advances CBTN’s tumoroid modeling and medulloblastoma classifier initiatives, critical building blocks for precision research and targeted therapies.

Winning With Wyatt supports pediatric brain and spinal tumor research at leading medical institutions, including Lurie Children’s in Chicago. The foundation is dedicated to fundraising, building awareness about the impact brain and spinal tumors have on children, and advocating for more advanced treatment. Winning With Wyatt was established after a child, family, and community experienced the impact of pediatric brain tumors in multiple children, including Wyatt.